- Home
- AOMR vs PROF Comparison
AOMR vs PROF Comparison
Compare AOMR & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AOMR
- PROF
- Stock Information
- Founded
- AOMR 2018
- PROF N/A
- Country
- AOMR United States
- PROF Canada
- Employees
- AOMR N/A
- PROF N/A
- Industry
- AOMR Real Estate Investment Trusts
- PROF Medical/Dental Instruments
- Sector
- AOMR Real Estate
- PROF Health Care
- Exchange
- AOMR Nasdaq
- PROF Nasdaq
- Market Cap
- AOMR 217.2M
- PROF 221.6M
- IPO Year
- AOMR 2021
- PROF N/A
- Fundamental
- Price
- AOMR $10.08
- PROF $7.35
- Analyst Decision
- AOMR Buy
- PROF Strong Buy
- Analyst Count
- AOMR 6
- PROF 2
- Target Price
- AOMR $12.10
- PROF $11.40
- AVG Volume (30 Days)
- AOMR 97.4K
- PROF 70.6K
- Earning Date
- AOMR 03-04-2025
- PROF 03-06-2025
- Dividend Yield
- AOMR 12.70%
- PROF N/A
- EPS Growth
- AOMR N/A
- PROF N/A
- EPS
- AOMR 2.91
- PROF N/A
- Revenue
- AOMR $94,441,000.00
- PROF $8,984,000.00
- Revenue This Year
- AOMR N/A
- PROF $57.62
- Revenue Next Year
- AOMR $31.46
- PROF $160.54
- P/E Ratio
- AOMR $3.46
- PROF N/A
- Revenue Growth
- AOMR 455.18
- PROF 39.35
- 52 Week Low
- AOMR $8.88
- PROF $6.78
- 52 Week High
- AOMR $13.32
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- AOMR 64.08
- PROF 45.87
- Support Level
- AOMR $9.36
- PROF $7.17
- Resistance Level
- AOMR $10.16
- PROF $7.55
- Average True Range (ATR)
- AOMR 0.25
- PROF 0.35
- MACD
- AOMR 0.07
- PROF 0.00
- Stochastic Oscillator
- AOMR 89.74
- PROF 47.11
About AOMR Angel Oak Mortgage REIT Inc.
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation, across interest rates and credit cycles.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.